Screening diseases through pharmacogenomics with NalaGenetics' Levana Sani
Description
Levana Sani is the co-founder and CEO of NalaGenetics. In this episode, Levana shares how her background in biochemistry and her MBA from Harvard Business School helped shape her understanding of the business side of science. She explains the four main problems NalaGenetics aims to solve in the field of genetic testing and the challenges they faced in the early stages. Additionally, she highlights the differences in commercialisation in Singapore and Indonesia, and the current challenges faced with the adoption and application of pharmacogenomics in clinics.
Host: Jessie Wong
Editors: Jessie Wong, John Joson Ng
The show notes and transcripts for the episode can be found on
nucleatesingapore.substack.com. For feedback or recommendations on who we should talk to next, please reach out to Joson Ng via johnjoson.n@nucleate.org.
01:00 Introduction
05:09 Early beginnings of NalaGenetics
12:11 Product development and market expansion
17:10 Technology and democratization of genetics
24:15 Future outlook
United States
